Glucosamine and Chondroitin: What They Do for Joints

Ranked by how much each one shapes the current position on these supplements.

These supplements have not been shown to be harmful, and they have been tested more thoroughly than almost any other supplement on the market. Both of those facts point the same way: the honest summary is that they do not do much, rather than that the jury is out.

This is a documentary review of published trials and guidance rather than advice about what you should take. Five findings were selected because between them they account for how a supplement that was standard advice fifteen years ago came to be one that national guidance advises against.

The sources read were the GAIT trial published in the New England Journal of Medicine in 2006; a 2018 review of what has been learned since GAIT; and NICE guideline NG226 on osteoarthritis. Evidence checked in August 2026.

Two honest limits worth stating. Some European trials of glucosamine sulfate, particularly the prescription-grade crystalline preparation used in parts of Europe, have reported positive results, and several were manufacturer-funded, which is the core of the ongoing dispute described below. And no prices are quoted here, because retail costs could not be verified for this review.

Notice how much has been spent testing this. Glucosamine has been studied more than any other joint supplement. That is important: an absence of benefit after this much investigation is a stronger conclusion than an absence of evidence.

Watch for who funded each trial. This is the recurring theme in the glucosamine literature, and independently funded trials have tended to be more negative than manufacturer-funded ones.

Separate personal experience from average effect. A trial finding no average benefit is compatible with individuals genuinely feeling better, whether through a real response or a placebo effect. Both are common in pain conditions.

Consider what it is being taken instead of. This is the strongest argument against it, and it has nothing to do with the supplement itself. Someone taking glucosamine daily and doing no strengthening work has swapped a large effect for a negligible one.

Judge it by stopping. If you have taken it for years and are unsure, stopping for eight weeks is the only informative test available to you.

What the trial did

The Glucosamine/chondroitin Arthritis Intervention Trial, published in 2006, randomised 1,583 people with symptomatic knee osteoarthritis into five groups: glucosamine 1500mg daily, chondroitin sulfate 1200mg daily, both together, celecoxib 200mg daily, or placebo, over 24 weeks. It was multicentre, double-blind and independently funded through the US National Institutes of Health.

What it found

Glucosamine and chondroitin sulfate, alone or in combination, did not significantly reduce knee pain compared with placebo in the overall group. The primary outcome was the proportion achieving a 20% reduction in pain, and neither supplement reached significance on it.

Why it carries weight

It is large, independently funded, double-blind, and included an active drug comparator, which is unusual in supplement research and lets you see whether the trial could detect an effect at all.

Limits and cautions

It used glucosamine hydrochloride rather than the sulfate form, which is the basis of the objection covered below. Twenty-four weeks is a reasonable duration for symptom outcomes and short for anything structural.

Why it ranks first

It is the single most informative study on the question, and it is the one everything since has had to be read against.

What was found

An exploratory analysis within GAIT suggested that the combination of glucosamine and chondroitin might be effective in the subgroup of participants with moderate to severe knee pain, as opposed to mild pain.

Why it is not the headline

That subgroup contained only around 70 to 72 participants per treatment group. The trial authors were explicit that the finding should be viewed as hypothesis-generating rather than conclusive.

Why this matters generally

Subgroup analyses in trials that missed their primary outcome are the most common source of overstated supplement claims. With enough subgroups, one will reach significance by chance, which is why they generate the next study rather than the next recommendation.

What happened next

Subsequent work has not established the moderate-to-severe subgroup finding as a reliable effect, and reviews of the literature since GAIT have not resolved it in favour of the supplements.

Why it ranks second

It is the strongest positive signal in the best trial, and understanding why it does not carry the day explains most of the disagreement that followed.

The claim

That GAIT used glucosamine hydrochloride, while the positive European trials used glucosamine sulfate, particularly a patented crystalline preparation, and that the two are not equivalent.

What is genuinely true

The two salts are different compounds and there are reasons to think absorption may differ. Some European trials of the crystalline sulfate preparation reported positive results on symptoms and on joint space narrowing, and it is available on prescription in several European countries.

What weakens the argument

Several of those trials were funded by the manufacturer of that preparation, and independently funded trials have tended to be more negative. Meta-analyses that account for funding source find the effect shrinks substantially. UK guidance has not been persuaded by the distinction.

The practical position

Most glucosamine sold over the counter in the UK is not the prescription-grade crystalline sulfate preparation used in the positive European trials, so even accepting the argument at its strongest, it may not apply to the product on the shelf.

Why it ranks third

It is the most substantive scientific objection to the negative evidence, and it remains unresolved rather than settled in either direction.

What the guidance says

NICE guideline NG226 on osteoarthritis is unambiguous: do not offer glucosamine for the management of osteoarthritis. It appears in the same do-not-offer recommendation as acupuncture, electrotherapy, hyaluronan injections and arthroscopic lavage.

Why that changed

Earlier guidance was more permissive. The accumulation of larger and better-controlled trials, GAIT prominently among them, shifted the balance from uncertain to negative, and NICE reflected that.

What it means in practice

Your GP will not prescribe it and may advise against buying it. The recommendation is directed at clinicians offering treatments rather than at individuals choosing what to buy, which is a genuine distinction.

Limits and cautions

NICE assessments consider cost-effectiveness alongside clinical effectiveness, so a do-not-offer recommendation reflects both. For an individual buying it themselves, the cost-effectiveness half of that calculation is theirs to make.

Why it ranks fourth

It is the practical consequence of the three findings above, and it is what most people encounter when they ask a clinician about it.

What the evidence shows

Glucosamine and chondroitin are well tolerated. In GAIT, adverse events were mild and comparable across groups, including placebo. There is no signal of serious harm from ordinary doses.

The cautions that do exist

Glucosamine is commonly derived from shellfish shells, which matters for anyone with a shellfish allergy, though the allergen is usually in the flesh rather than the shell. It can interact with warfarin and increase bleeding risk, so anyone on anticoagulants should check with a pharmacist. There is some evidence of effects on blood glucose, worth knowing about in diabetes.

Why safety is not the argument

The case against these supplements has never been that they are dangerous. It is that the effect on pain is not distinguishable from placebo in the best trials, so the money and the daily habit buy very little.

The real cost

The meaningful cost is displacement. Someone taking glucosamine daily who has not started a strengthening programme has substituted a supplement with no demonstrated effect for the treatment with the largest one.

Why it ranks fifth

It answers the question people ask second, which is whether it can do harm, and reframes it towards the question that matters more.

The first and fourth rows together are the whole picture. These are among the safest things you can take and among the most thoroughly tested, and the testing did not find what it was looking for.

If you are considering starting glucosamine, the evidence does not support it, and there are better-supported options for knee osteoarthritis.

If you already take it and are convinced it helps, it is safe and inexpensive, and there is no need to stop. If you want to know whether it is doing anything, stop for eight weeks and see.

If you take it and have never done a strengthening programme, that is the swap worth making, since exercise is the core NICE recommendation for osteoarthritis.

If you take warfarin or another anticoagulant, check with a pharmacist, because glucosamine can increase bleeding risk.

If you have a shellfish allergy, look for a vegetarian glucosamine produced by fermentation rather than from shellfish shells.

If you have been told glucosamine sulfate is different from what was tested, that argument is real and unresolved, and most UK over-the-counter products are not the prescription-grade preparation the positive European trials used.

The belief that persists, more than for anything else in this area, is that glucosamine rebuilds cartilage. It is an intuitive idea and it is what the packaging implies: cartilage contains glucosamine, so supplying more should help. Digestion does not work that way, and eating collagen no more rebuilds a tendon than eating bone rebuilds a femur.

What is worth acknowledging is why the belief survives such a large negative trial. Osteoarthritis fluctuates over months, most people start a supplement when symptoms are bad, and symptoms tend to move back towards their average afterwards regardless of what was started. That pattern produces a convincing personal experience for a great many people, which is precisely why the placebo-controlled trial exists and why it found what it found.

None of that makes it worth arguing about with someone who feels better. The conversation worth having is what else is being done, because a strengthening programme has an effect size this supplement has never demonstrated. If you are unsure whether the pain you have is the sort that responds to loading, a free discovery and triage call is a quick way to find out.

Does glucosamine work for knee arthritis?
The GAIT trial randomised 1,583 people with knee osteoarthritis and found that glucosamine, chondroitin, and the two combined did not significantly reduce pain compared with placebo overall. NICE guideline NG226 advises clinicians not to offer glucosamine for osteoarthritis.

What is the difference between glucosamine sulfate and glucosamine hydrochloride?
They are different salts of the same molecule, and absorption may differ. GAIT used the hydrochloride form, while several positive European trials used a prescription-grade crystalline sulfate preparation. Many of those were manufacturer-funded, the distinction remains disputed, and most UK over-the-counter products are not that prescription-grade preparation.

Does glucosamine rebuild cartilage?
No. Glucosamine is a component of cartilage, and taking it by mouth does not direct it to joint surfaces or stimulate cartilage repair. Trials looking at structural outcomes have not established a reliable protective effect, and digestion breaks the compound down like any other nutrient.

Is glucosamine safe to take?
Yes, for most people. Adverse events in GAIT were mild and comparable to placebo. The cautions are that it can interact with warfarin and increase bleeding risk, it is often derived from shellfish, and it may affect blood glucose, which is worth knowing about in diabetes.

Should I stop taking glucosamine?
Not necessarily. It is safe and inexpensive, so continuing one you believe helps is a reasonable personal decision even though the evidence does not support recommending it. If you want to know whether it is doing anything, stop for eight weeks and compare.

How long does glucosamine take to work?
Products typically suggest allowing eight to twelve weeks. The trials that ran for 24 weeks did not find a significant benefit over placebo in that time, so a longer trial period is unlikely to change the answer.

What should I take instead of glucosamine for joint pain?
For knee osteoarthritis, curcumin has the most consistent positive trial results among supplements, though the evidence quality is low. For rheumatoid arthritis, omega-3 has the best support. More importantly, therapeutic exercise is the core treatment in NICE guidance and has a considerably larger effect than any supplement studied.